Biblio

Export 1231 results:
Author [ Title(Asc)] Type Year
Filters: First Letter Of Last Name is D  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
M
C. Merino-Zamorano, de Retana, S. Fernández, Montañola, A., Batlle, A., Saint-Pol, J., Mysiorek, C., Gosselet, F., Montaner, J., and Hernández-Guillamon, M., “Modulation of Amyloid-β1-40 Transport by ApoA1 and ApoJ Across an in vitro Model of the Blood-Brain Barrier.”, J Alzheimers Dis, vol. 53, no. 2, pp. 677-91, 2016.
S. J. B. Vos, van Boxtel, M. P. J., Schiepers, O. J. G., Deckers, K., de Vugt, M., Carrière, I., Dartigues, J. - F., Pérès, K., Artero, S., Ritchie, K., Galluzzo, L., Scafato, E., Frisoni, G. B., Huisman, M., Comijs, H. C., Sacuiu, S. F., Skoog, I., Irving, K., O'Donnell, C. A., Verhey, F. R. J., Visser, P. Jelle, and Köhler, S., “Modifiable Risk Factors for Prevention of Dementia in Midlife, Late Life and the Oldest-Old: Validation of the LIBRA Index.”, J Alzheimers Dis, vol. 58, no. 2, pp. 537-547, 2017.
S. J. B. Vos, van Boxtel, M. P. J., Schiepers, O. J. G., Deckers, K., de Vugt, M., Carrière, I., Dartigues, J. - F., Pérès, K., Artero, S., Ritchie, K., Galluzzo, L., Scafato, E., Frisoni, G. B., Huisman, M., Comijs, H. C., Sacuiu, S. F., Skoog, I., Irving, K., O'Donnell, C. A., Verhey, F. R. J., Visser, P. Jelle, and Köhler, S., “Modifiable Risk Factors for Prevention of Dementia in Midlife, Late Life and the Oldest-Old: Validation of the LIBRA Index.”, J Alzheimers Dis, vol. 58, no. 2, pp. 537-547, 2017.
S. J. B. Vos, van Boxtel, M. P. J., Schiepers, O. J. G., Deckers, K., de Vugt, M., Carrière, I., Dartigues, J. - F., Pérès, K., Artero, S., Ritchie, K., Galluzzo, L., Scafato, E., Frisoni, G. B., Huisman, M., Comijs, H. C., Sacuiu, S. F., Skoog, I., Irving, K., O'Donnell, C. A., Verhey, F. R. J., Visser, P. Jelle, and Köhler, S., “Modifiable Risk Factors for Prevention of Dementia in Midlife, Late Life and the Oldest-Old: Validation of the LIBRA Index.”, J Alzheimers Dis, vol. 58, no. 2, pp. 537-547, 2017.
P. G McFall, McDermott, K. L., and Dixon, R. A., “Modifiable Risk Factors Discriminate Memory Trajectories in Non-Demented Aging: Precision Factors and Targets for Promoting Healthier Brain Aging and Preventing Dementia.”, J Alzheimers Dis, vol. 70, no. s1, pp. S101-S118, 2019.
K. K. Indorewalla, O'Connor, M. K., Budson, A. E., DiTerlizzi, C. Guess, and Jackson, J., “Modifiable Barriers for Recruitment and Retention of Older Adults Participants from Underrepresented Minorities in Alzheimer's Disease Research.”, J Alzheimers Dis, vol. 80, no. 3, pp. 927-940, 2021.
R. J. Dougherty, Schultz, S. A., Kirby, T. K., Boots, E. A., Oh, J. M., Edwards, D., Gallagher, C. L., Carlsson, C. M., Bendlin, B. B., Asthana, S., Sager, M. A., Hermann, B. P., Christian, B. T., Johnson, S. C., Cook, D. B., and Okonkwo, O. C., “Moderate Physical Activity is Associated with Cerebral Glucose Metabolism in Adults at Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1089-1097, 2017.
M. L. Alosco, Duskin, J., Besser, L. M., Martin, B., Chaisson, C. E., Gunstad, J., Kowall, N. W., McKee, A. C., Stern, R. A., and Tripodis, Y., “Modeling the Relationships Among Late-Life Body Mass Index, Cerebrovascular Disease, and Alzheimer's Disease Neuropathology in an Autopsy Sample of 1,421 Subjects from the National Alzheimer's Coordinating Center Data Set.”, J Alzheimers Dis, vol. 57, no. 3, pp. 953-968, 2017.
E. Wawrziczny, Berna, G., Ducharme, F., Kergoat, M. - J., Pasquier, F., and Antoine, P., “Modeling the Distress of Spousal Caregivers of People with Dementia.”, J Alzheimers Dis, vol. 55, no. 2, pp. 703-716, 2017.
Q. Yu, Du, F., Douglas, J. T., Yu, H., Yan, S. ShiDu, and Yan, S. Fang, “Mitochondrial Dysfunction Triggers Synaptic Deficits via Activation of p38 MAP Kinase Signaling in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.”, J Alzheimers Dis, vol. 59, no. 1, pp. 223-239, 2017.
Q. Yu, Du, F., Douglas, J. T., Yu, H., Yan, S. ShiDu, and Yan, S. Fang, “Mitochondrial Dysfunction Triggers Synaptic Deficits via Activation of p38 MAP Kinase Signaling in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.”, J Alzheimers Dis, vol. 59, no. 1, pp. 223-239, 2017.
L. Guo, Tian, J., and Du, H., “Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1071-1086, 2017.
E. C. Edmonds, Delano-Wood, L., Jak, A. J., Galasko, D. R., Salmon, D. P., and Bondi, M. W., “"Missed" Mild Cognitive Impairment: High False-Negative Error Rate Based on Conventional Diagnostic Criteria.”, J Alzheimers Dis, vol. 52, no. 2, pp. 685-91, 2016.
I. H. K. Dias, Brown, C. L., Shabir, K., M Polidori, C., and Griffiths, H. R., “miRNA 933 Expression by Endothelial Cells is Increased by 27-Hydroxycholesterol and is More Prevalent in Plasma from Dementia Patients.”, J Alzheimers Dis, vol. 64, no. 3, pp. 1009-1017, 2018.
M. Ruiz, Arias, A., Sánchez-Llanos, E., Gil, M. Pilar, López-Ortega, R., Dakterzada, F., Purroy, F., and Piñol-Ripoll, G., “Minor Hallucinations in Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 2, pp. 543-549, 2018.
D. J. Quintana-Hernández, Rojas-Hernández, J., Del Pino, A. Santana-, Suárez, C. Céspedes, Silva, M. Pellejero, Miró-Barrachina, M. Teresa, Fernández, I. Ibáñez, López, J. Antonio Es, and Borkel, L. F., “Mindfulness Prevents Depression and Psychopathology in Elderly People with Mild to Moderate Alzheimer's Disease: A Randomized Clinical Trial.”, J Alzheimers Dis, vol. 91, no. 1, pp. 471-481, 2023.
D. J. Quintana-Hernández, Miró-Barrachina, M. T., Ibáñez-Fernández, I. J., Del Pino, A. Santana-, Quintana-Montesdeoca, M. P., de Vera, B. Rodríguez, Morales-Casanova, D., Pérez-Vieitez, M. Del Carmen, Rodríguez-García, J., and Bravo-Caraduje, N., “Mindfulness in the Maintenance of Cognitive Capacities in Alzheimer's Disease: A Randomized Clinical Trial.”, J Alzheimers Dis, vol. 50, no. 1, pp. 217-32, 2016.
D. J. Quintana-Hernández, Miró-Barrachina, M. T., Ibáñez-Fernández, I. J., Del Pino, A. Santana-, Quintana-Montesdeoca, M. P., de Vera, B. Rodríguez, Morales-Casanova, D., Pérez-Vieitez, M. Del Carmen, Rodríguez-García, J., and Bravo-Caraduje, N., “Mindfulness in the Maintenance of Cognitive Capacities in Alzheimer's Disease: A Randomized Clinical Trial.”, J Alzheimers Dis, vol. 50, no. 1, pp. 217-32, 2016.
K. Dhana, James, B. D., Agarwal, P., Aggarwal, N. T., Cherian, L. J., Leurgans, S. E., Barnes, L. L., Bennett, D. A., and Schneider, J. A., “MIND Diet, Common Brain Pathologies, and Cognition in Community-Dwelling Older Adults.”, J Alzheimers Dis, vol. 83, no. 2, pp. 683-692, 2021.
C. LoBue, Kelley, B. J., Hart, J., Helphrey, J., Schaffert, J., C Cullum, M., Peters, M. E., and Douglas, P. M., “Mild Traumatic Brain Injury is Related to Elevated Cerebrospinal Fluid Tau in Alzheimer's Disease Dementia.”, J Alzheimers Dis, vol. 87, no. 4, pp. 1491-1496, 2022.
L. Fenton, S Han, D., DiGuiseppi, C. G., Fowler, N. R., Hill, L., Johnson, R. L., Peterson, R. A., Knoepke, C. E., Matlock, D. D., Moran, R., Karlawish, J., and Betz, M. E., “Mild Cognitive Impairment is Associated with Poorer Everyday Decision Making.”, J Alzheimers Dis, vol. 94, no. 4, pp. 1607-1615, 2023.
I. De Anda-Duran, Kolachalama, V. B., Carmichael, O. T., Hwang, P. H., Fernandez, C., Au, R., Bazzano, L. A., and Libon, D. J., “Midlife Neuropsychological Profiles and Associated Vascular Risk: The Bogalusa Heart Study.”, J Alzheimers Dis, vol. 94, no. 1, pp. 101-113, 2023.
R. Tortelli, Lozupone, M., Guerra, V., Barulli, M. Rosaria, Imbimbo, B. P., Capozzo, R., Grasso, A., Tursi, M., Di Dio, C., Sardone, R., Giannelli, G., Seripa, D., Misciagna, G., Panza, F., and Logroscino, G., “Midlife Metabolic Profile and the Risk of Late-Life Cognitive Decline.”, J Alzheimers Dis, vol. 59, no. 1, pp. 121-130, 2017.
A. Di Meco and Praticò, D., “MicroRNAs as Therapeutic Targets for Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 2, pp. 367-72, 2016.
P. R. Manzine, Pelucchi, S., Horst, M. A., Vale, F. A. C., Pavarini, S. C. I., Audano, M., Mitro, N., Di Luca, M., Marcello, E., and Cominetti, M. R., “microRNA 221 Targets ADAM10 mRNA and is Downregulated in Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 1, pp. 113-123, 2018.

Pages